ACAD Fell 22% on a Trial Miss. The Business Is Different.
Monday was brutal for ACADIA Pharmaceuticals. ACAD sank 22.28% as investors revisited remlifanserin’s miss in...
Newsletters
Not Tesla. Not SpaceX. Silver.
A note from our friends at Behind the Markets(ad) Dear Friend, I’m giving you a...
This $5 Stock Could Hit $50 by January This “Musk Target” to 10X By January 1st?
A note from our friends at The Oxford Club(ad) Dear reader, This stock trades for...
Boeing Got a Record Order and Still Can’t Keep Up
Two numbers landed in the same week and they point in opposite directions. On November...
The Shocking Truth about the AI Bubble
A note from our friends at The Oxford Club(ad) The Shocking Truth about the AI...
150 years ago, they built a secret Europe…
A note from our friends at The Agora Companies(ad) Back in the 1860s, settlers from...
Barrick Reports Monday Into Gold’s Worst Drawdown in a Decade
When Barrick Mining (NYSE: B) releases third-quarter results Monday morning, analysts will scan the headline...
Gold can’t be printed, frozen, or inflated away
A note from our friends at American Alternative Assets_FBD(ad) The U.S. national debt recently crossed...
Elon Musk: This Could be 180 Times Bigger than SpaceX IPO
November 8, 2026 Bonus Content: Honda’s EV Reset Puts Auto PGM Demand Back in Focus...
Gold Near $4,000 While Mortgage Rates Hold Above 7%
The number getting all the attention is 7.18%. That is where Freddie Mac’s Primary Mortgage...